WSTAM
SRPT icon

Wilbanks Smith & Thomas Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed -$32K – 1181
2018
Q3 		$32K Buy
+200
New +$32K ﹤0.01% 779